$23.77
0.381.60%
At close: -
$23.95
0.180.78%
After Hours: 7:04 PM EDT
Comments
Loading...
Structure Therapeutics (GPCR) Forecast
NewsEarningsStructure Therapeutics (GPCR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestStructure Therapeutics (NASDAQ:GPCR) Stock Quotes, Forecast and News Summary
Structure Therapeutics Stock (NASDAQ: GPCR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Structure Therapeutics (GPCR) stock?
You can purchase shares of Structure Therapeutics (NASDAQ:GPCR) through any online brokerage.
Who are Structure Therapeutics (GPCR) competitors?
Other companies in Structure Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Phibro Animal Health (NASDAQ:PAHC) and Tarsus Pharmaceuticals (NASDAQ:TARS).
What is the forecast, or price target, for Structure Therapeutics (GPCR) stock?
Structure Therapeutics has a consensus price target of $75.55.
What is the current price for Structure Therapeutics (GPCR)?
The stock price for Structure Therapeutics (NASDAQ: GPCR) is $23.95 last updated February 21, 2025 at 7:04 PM EST.
Does Structure Therapeutics (GPCR) pay a dividend?
There are no upcoming dividends for Structure Therapeutics.
When is Structure Therapeutics (NASDAQ:GPCR) reporting earnings?
Structure Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Structure Therapeutics (GPCR) going to split?
There is no upcoming split for Structure Therapeutics.
What sector and industry does Structure Therapeutics (GPCR) operate in?
Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.